Green amit munshi acquires shares arena pharmaceuticals inc arna stock

Related Stories:



amit munshi acquires shares arena pharmaceuticals inc arna stock

independent portfolio consultants inc lowers stake etrade financial corp etfc

janus capital group inc jns position boosted sit investment associates

ziopharm oncology inc ziop stock rating upgraded zacks investment research

sit investment associates inc acquires shares teleflex incorporated tfx

public lands stake outdoors enthusiasts head dc

discover financial services dfs price target cut analysts oppenheimer holdings inc

Green Sun May 21 2017 10:06:36 GMT+0000 (UTC)
WHERE THE PARTY'S AT -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) insider Amit Munshi bought 50,000 shares of the stock in a transaction on Wednesday, April 26th. The shares were acquired at an average cost of $1.41 per share, with a total value of $70,500.00. Following the
Alder Biopharmaceuticals Inc (NASDAQ:ALDR)‘s stock had its “buy” rating restated by equities research analysts at Aegis in a research report issued to clients and investors on Tuesday, April 25th. They presently have a $
Media coverage about Union Bankshares Corp (NASDAQ:UBSH) has been trending somewhat positive on Sunday, according to AlphaOne Sentiment. The research firm, a division of Accern, scores the sentiment of press coverage by reviewing more than 20 million
First Mercantile Trust Co. decreased its position in shares of Voya Financial Inc (NYSE:VOYA) by 4.6% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 16,700 shares of the asset manager’s stock
Jefferies Group LLC reiterated their buy rating on shares of Royal Dutch Shell Plc (LON:RDSA) in a research report released on Friday, May 5th. They currently have a GBX 2,700 ($34.85) price target on the stock. Several other research analysts have a
Numis Securities Ltd restated their add rating on shares of Smith & Nephew plc (LON:SN) in a research note published on Friday, May 5th. The firm currently has a GBX 1,350 ($17.43) target price on the stock. Other equities analysts have also
Zacks Investment Research upgraded shares of Tivity Health Inc (NASDAQ:TVTY) from a hold rating to a buy rating in a research report sent to investors on Wednesday, April 26th. The brokerage currently has $32.00 target price on the stock. According t
Whittier Trust Co. maintained its stake in shares of General Finance Co. (NASDAQ:GFN) during the first quarter, according to its most recent disclosure with the SEC. The firm owned 62,459 shares of the business services provider’s stock at